Do patients and physicians weigh drug risks differently? FDA researchers plan to find out
Before starting a new prescription drug, patients and their doctors have a whole slate of questions to consider, including how risks weigh against certain benefits like efficacy or convenience. But do patients view the tradeoffs differently than physicians?
That’s what the FDA’s Office of Prescription Drug Promotion (OPDP) wants to find out with its latest study, which will be officially announced early next week.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.